First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - NEWHAVEN PHARMACIES LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: NEWHAVEN PHARMACIES LIMITED, 213 ST. JOHN STREET, LONDON, EC1V 4LY. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 September 2023. The company was incorporated on 23 June 1961.

The accounts next due date is 30 June 2025. There are 10 mortgages, 5 satisfied, none part satisfied and 5 unsatisfied.

The above was based on public record information as at 12 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 00696374
Date Incorporated: 23 June 1961
Date Latest Accounts: 30 September 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 00696374
Annual Return: 12 November 2015
Registered Office: 213 ST. JOHN STREET, LONDON, EC1V 4LY
SIC Code and Operations: 47730
SECURED CREDITORS
Number of Mortgages 10
Satisfied Mortgages 5
Part Satisfied Mortgages 0
Unsatisfied Mortgages 5
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

NEWHAVEN PHARMACIES LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 22 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
02292047 NEWHAVEN PILOTAGE AND MARINE SERVICES LIMITED Dissolved
10361466 NEWHAVEN PIZZA LTD Dissolved
01923744 NEWHAVEN PORT & PROPERTIES LIMITED Active
06259487 NEWHAVEN PRESS LIMITED Dissolved
08180671 NEWHAVEN PRINT MANAGEMENT SWINTON LTD Liquidation

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd